Solis Agrosciences, a St.Louis, MO-based company developing Agtech research services, received Series A funding from Cultivation Capital.
The amount of the deal was not disclosed.
The company intends to use the funds to accelerate its commercial growth and expand its product offerings.
Led by CEO Charlie Bolten, Solis Agrosciences Solis provides high-quality Agtech research services. They generate gene-edited and transgenic crops, plant phenotype and efficacy data, end-to-end genomics sequencing services, and individually tailored research solutions for startup and corporate customers.
The company’s major investors also are Hermann Companies, Jim McKelvey’s Saloniki Investments, BioGenerator Ventures, and QRM Capital. Additional investors included St. Louis Arch Angels, Missouri Technology Corporation, Helix Fund, CIG Spectrum, Hypha Life Sciences, and various angel investors.
FinSMEs
03/03/2025